Delivery Order SPE2DB20D2002-SPE2DB22FL11X
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,209.55 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of PREVNAR 13 syringes, a pneumococcal vaccine, with a performance period through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver PREVNAR 13 syringes. The $111,441.26 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $95,475.09, is for the delivery of PREVNAR 13 SYRINGE 0.5ML, a vaccine product. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
- The U.S. Defense Logistics Agency (DLA) awarded a $41,257.07 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of PREVNAR 13 syringes (0.5 mL). This contract does not have a set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs. The...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,548.24 firm-fixed-price delivery order is for the supply of PREVNAR 13 syringes (0.5 mL) and has a completion date of May 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Prevnar 13 syringes. The contract, valued at $76,654.72, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to provide a...
- This federal contract award, valued at $8,184.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PREVNAR 13 syringes (0.5 mL) and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). Cencora, Inc. holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,972.70 firm-fixed-price delivery order is for the supply of PREVNAR 13 syringes. The award has an ultimate completion date of January 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). This delivery...
- The Defense Logistics Agency (DLA) awarded a $18,424.84 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of PREVNAR 13 syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $7,268.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PREVNAR 13 syringes, a pneumococcal vaccine, and has a final completion date of September 13, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL11XDelivery Order
This federal contract award, valued at $9,441.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PREVNAR 13 syringes. The contract is a delivery order and has a firm fixed price. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the System for Award Management (SAM.gov). This contract is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 1/10/22 |